文献速递淋巴瘤

STAT介导的BATF3上调致癌轴在经典型霍奇金淋巴瘤和间变性大细胞淋巴瘤中促进MYC活性

An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
PubMed 文献 · Leukemia · 2017-06-29

经典型霍奇金淋巴瘤(cHL)和间变性大细胞淋巴瘤(ALCL)高表达AP-1转录因子BATF3。研究发现BATF3与JUN/JUNB相互作用,敲低BATF3对cHL和ALCL细胞系有毒性并降低增殖与存活;BATF3结合MYC启动子并促进MYC活性,JAK/STAT信号调控BATF3表达,STAT蛋白直接调控BATF3,揭示一个致癌轴。

要点

  • cHL(21/30)、原发纵隔B细胞淋巴瘤(8/9)和CD30+弥漫大B细胞淋巴瘤(15/20)频繁表达BATF3蛋白。
  • 敲低BATF3对cHL和ALCL细胞系有毒性,降低其增殖和存活。
  • JAK/STAT信号调控BATF3表达,STAT蛋白直接调控BATF3,BATF3结合MYC启动子促进MYC活性。

核心结论

  • 识别出STAT介导的BATF3表达对淋巴瘤细胞存活至关重要,并在cHL和ALCL中促进MYC活性,从而确定这些淋巴瘤中的一个新致癌轴。

研究设计与样本

  • 研究使用cHL和ALCL细胞系,通过质谱和免疫共沉淀检测BATF3与JUN/JUNB相互作用。
  • 使用短发夹RNA敲低BATF3评估对cHL和ALCL细胞系的毒性、增殖和存活影响。
  • 通过染色质免疫沉淀证实STAT蛋白对BATF3的直接调控,并确认BATF3与MYC启动子结合。

主要发现

  • cHL(21/30)、原发纵隔B细胞淋巴瘤(8/9)和CD30+弥漫大B细胞淋巴瘤(15/20)频繁表达BATF3蛋白。
  • BATF3与JUN和JUNB在cHL和ALCL细胞系中相互作用。
  • 敲低BATF3对cHL和ALCL细胞系有毒性,降低其增殖和存活。
  • MYC是BATF3的关键靶点,BATF3结合MYC启动子。
  • 化学抑制JAK2降低BATF3表达,白细胞介素13刺激诱导cHL细胞系中BATF3表达;染色质免疫沉淀证实STAT蛋白直接调控BATF3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Classical Hodgkin lymphoma (cHL) and anaplastic large cell lymphoma (ALCL) feature high expression of activator protein-1 (AP-1) transcription factors, which regulate various physiological processes but also promote lymphomagenesis. The AP-1 factor basic leucine zipper transcription factor, ATF-like 3 (BATF3), is highly transcribed in cHL and ALCL; however, its functional importance in lymphomagenesis is unknown. Here we show that proto-typical CD30+ lymphomas, namely cHL (21/30) and primary mediastinal B-cell lymphoma (8/9), but also CD30+ diffuse large B-cell lymphoma (15/20) frequently express BATF3 protein. Mass spectrometry and co-immunoprecipitation established interactions of BATF3 with JUN and JUNB in cHL and ALCL lines. BATF3 knockdown using short hairpin RNAs was toxic for cHL and ALCL lines, reducing their proliferation and survival. We identified MYC as a critical BATF3 target and confirmed binding of BATF3 to the MYC promoter. JAK/STAT signaling regulated BATF3 expression, as chemical JAK2 inhibition reduced and interleukin 13 stimulation induced BATF3 expression in cHL lines. Chromatin immunoprecipitation substantiated a direct regulation of BATF3 by STAT proteins in cHL and ALCL lines. In conclusion, we identified STAT-mediated BATF3 expression that is essential for lymphoma cell survival and promoted MYC activity in cHL and ALCL, hence we recognized a new oncogenic axis in these lymphomas.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Lollies A, Hartmann S, Schneider M, et al. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma. Leukemia. 2017. PMID: 28659618. doi:10.1038/leu.2017.203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。